Parallax Health Sciences Announces Conference Call To Discuss The Status Of Its 10-K And 10-Q Filings And Other Financial Matters

SANTA MONICA, Calif., May 5, 2017 /PRNewswire/ -- Parallax Health Sciences, Inc. ("Parallax" or the "Company") (OTC: PRLX), has scheduled a conference call to address various financial matters, with an emphasis on the status of the Company's SEC filings, and the actions being taken to remedy the delinquencies of the Company's Annual 10-K filings, and related quarterly interim filings. In addition, the Chief Financial Officer, Calli Bucci, will report on the status of the Company's pending 2015 and 2016 financial statement audits, and the Company's current results of operations.

Topics:

• Audited results of operations of subsidiary, Roxsan Pharmacy, Inc. for 2013 and 2014
• Pending financial statement audits for 2015 and 2016
• Delinquent Annual 10-K's and all quarterly interim 10-Q filings
• 2017 and timely filings
• Summary and schedule of the next financial update

ABOUT PARALLAX HEALTH SCIENCES, INC.

Parallax Health Sciences, Inc. is an innovative health-care company headquartered in Santa Monica, CA, which operates four subsidiaries/divisions in Pharmaceuticals, Diagnostics, Behavioral Health, and Remote Patient Monitoring. Each division targets a separate synergistic vertical market that complements and strengthens each other and the Parallax value proposition.

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements within the meaning of Sec 27A of the Securities Act of 1933, as amended, and Sec 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond the Company's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in the Company's reports filed with the SEC. The Company is under no obligation to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Mark Bernhard, 310-899-4442

SOURCE Parallax Health Sciences, Inc.

Related Links

http://www.parallaxhealthsciences.com